| Literature DB >> 29122905 |
Cyriac Abby Philips1, Nikhil Phadke2, Karthik Ganesan3, Philip Augustine4.
Abstract
Patients with severe alcoholic hepatitis (SAH) have high mortality in the presence of steroid unresponsiveness in the absence of clear treatment recommendations. Liver transplantation is the curative option in such cases but is controversial in the wake of severe infections, post-transplant recidivism and long waiting on deceased donor listing. Animal and human studies have shed light on the beneficial effects of gut microbiota modulation in alcoholic liver disease. We present the first report of faecal microbiota transplantation (FMT) in a steroid non-responder in whom, clinical, biochemical and liver disease severity scores improved post-FMT and demonstrate distinct bacterial population changes pre-FMT and post-FMT. Healthy donor FMT could be safe and efficacious in SAH not responding to corticosteroid treatment, as a bridge to liver transplantation (LT) or in candidates who are unwilling or not ideal for LT for improvement in short-term transplant free survival. Larger controlled studies are required for confirmation. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: alcoholic liver disease; cirrhosis; portal hypertension
Mesh:
Substances:
Year: 2017 PMID: 29122905 PMCID: PMC5695424 DOI: 10.1136/bcr-2017-222310
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X